IRA & Medicare drug price negotiation
Bayer CEO says company is ‘working on’ MFN in the US
Endpoints NewsTopic alignment 85
Bayer CEO Bill Anderson said the drugmaker is “working on” a most favored nation agreement, signaling that it is in talks with President Donald Trump’s administration. The German drugmaker was not part ...
Filed under
CMS Issues Final Rule on the Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program
AMCP (Academy of Managed Care Pharmacy)Topic alignment 95
CMS finalizes rule to codify Medicare Drug Price Negotiation Program
AHATopic alignment 95
Most-Favored-Nation Drug Pricing Framework: How Manufacturer Agreements Affect Medicaid Best Price, Contracts, and Compliance
Frier LevittTopic alignment 90
How the Biosimilars Access and Affordability Act Redefines IRA Delays
The Center for BiosimilarsTopic alignment 92